1887

Abstract

We investigated changes in serotypes and antimicrobial susceptibilities among 386 isolates of invasive collected from numerous hospitals in Korea from 1996 to 2008. Serotypes 19F (9.8 %), 23F (8.3 %), 19A (7.8 %), 6A (7.5 %), 3 (7.3 %), 9V (6.5 %), 6B (6.2 %), 14 (4.9 %), 1 (3.9 %), 11A (3.9 %) and 4 (3.1 %) represented 69.2 % of all isolates. While the overall proportion of PCV7 serotypes was stable over time, we observed modest decreases in children <5 years old and in adults ≥65 years old between 1996–1999 and 2007–2008. An increased prevalence of non-PCV7 serotypes in these age groups was primarily attributable to an increase in serotypes 3, 6A and 19A. Most invasive isolates showed high resistance rates to erythromycin (74.9 %), tetracycline (71.1 %) and clindamycin (61.7 %). Between 1996–2003 and 2004–2008, non-susceptibility rates to cefotaxime and multi-drugs (three or more classes) in PCV7 serotypes showed a declining trend, while in non-PCV7 serotypes there was an increasing trend. Non-PCV7 serotypes 6A and 19A, which mostly exhibited multidrug-resistant phenotypes (69.0 % and 76.7 % respectively), increased between 1996–2003 and 2004–2008. Although PCV7 was introduced in Korea in November 2003, pneumococcal vaccination has not been included in the national child vaccination programme. Our results provide details of serotype occurrence that will be useful when adoption of universal pneumococcal vaccination in Korea is being considered.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.058164-0
2013-08-01
2019-12-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/8/1204.html?itemId=/content/journal/jmm/10.1099/jmm.0.058164-0&mimeType=html&fmt=ahah

References

  1. Chen Y. Y. , Yao S. M. , Chou C. Y. , Chang Y. C. , Shen P. W. , Huang C. T. , Su H. P. , Li S. Y. . ( 2006; ). Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002–2003. . J Med Microbiol 55:, 1109–1114. [CrossRef] [PubMed]
    [Google Scholar]
  2. Choi E. H. , Kim S. H. , Eun B. W. , Kim S. J. , Kim N. H. , Lee J. , Lee H. J. . ( 2008; ). Streptococcus pneumoniae serotype 19A in children, South Korea. . Emerg Infect Dis 14:, 275–281. [CrossRef] [PubMed]
    [Google Scholar]
  3. CLSI ( 2008; ). Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement M100-S16. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  4. Dagan R. . ( 2009; ). Serotype replacement in perspective. . Vaccine 27: (Suppl 3), C22–C24. [CrossRef] [PubMed]
    [Google Scholar]
  5. Dagan R. , Klugman K. P. . ( 2008; ). Impact of conjugate pneumococcal vaccines on antibiotic resistance. . Lancet Infect Dis 8:, 785–795. [CrossRef] [PubMed]
    [Google Scholar]
  6. Eun B. W. , Kim S. J. , Cho E. Y. , Lee J. , Choi E. H. , Lee H. J. . ( 2010; ). Genetic structure of Streptococcus pneumoniae isolated from children in a tertiary care university hospital, in Korea, 1995 to 2005. . Diagn Microbiol Infect Dis 68:, 345–351. [CrossRef] [PubMed]
    [Google Scholar]
  7. Hausdorff W. P. , Feikin D. R. , Klugman K. P. . ( 2005; ). Epidemiological differences among pneumococcal serotypes. . Lancet Infect Dis 5:, 83–93.[PubMed] [CrossRef]
    [Google Scholar]
  8. Hicks L. A. , Harrison L. H. , Flannery B. , Hadler J. L. , Schaffner W. , Craig A. S. , Jackson D. , Thomas A. , Beall B. . & other authors ( 2007; ). Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. . J Infect Dis 196:, 1346–1354. [CrossRef] [PubMed]
    [Google Scholar]
  9. Imöhl M. , Reinert R. R. , Ocklenburg C. , van der Linden M. . ( 2010; ). Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. . J Clin Microbiol 48:, 1291–1296. [CrossRef] [PubMed]
    [Google Scholar]
  10. Isozumi R. , Ito Y. , Ishida T. , Hirai T. , Ito I. , Maniwa K. , Hayashi M. , Kagioka H. , Hirabayashi M. . & other authors ( 2008; ). Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan. . J Infect Chemother 14:, 258–261. [CrossRef] [PubMed]
    [Google Scholar]
  11. Jacobs M. R. , Bajaksouzian S. , Bonomo R. A. , Good C. E. , Windau A. R. , Hujer A. M. , Massire C. , Melton R. , Blyn L. B. . & other authors ( 2009; ). Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype. . J Clin Microbiol 47:, 64–72. [CrossRef] [PubMed]
    [Google Scholar]
  12. Jefferies J. M. , Smith A. J. , Edwards G. F. , McMenamin J. , Mitchell T. J. , Clarke S. C. . ( 2010; ). Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. . J Clin Microbiol 48:, 87–96. [CrossRef] [PubMed]
    [Google Scholar]
  13. Lee S. , Lee K. , Kang Y. , Bae S. . ( 2010; ). Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. . Microb Drug Resist 16:, 135–142. [CrossRef] [PubMed]
    [Google Scholar]
  14. Pai R. , Moore M. R. , Pilishvili T. , Gertz R. E. , Whitney C. G. , Beall B. . Active Bacterial Core Surveillance Team ( 2005; ). Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. . J Infect Dis 192:, 1988–1995. [CrossRef] [PubMed]
    [Google Scholar]
  15. Park I. H. , Park S. , Hollingshead S. K. , Nahm M. H. . ( 2007; ). Genetic basis for the new pneumococcal serotype, 6C. . Infect Immun 75:, 4482–4489. [CrossRef] [PubMed]
    [Google Scholar]
  16. Pichichero M. E. , Casey J. R. . ( 2007; ). Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. . JAMA 298:, 1772–1778. [CrossRef] [PubMed]
    [Google Scholar]
  17. Pillai D. R. , Shahinas D. , Buzina A. , Pollock R. A. , Lau R. , Khairnar K. , Wong A. , Farrell D. J. , Green K. . & other authors ( 2009; ). Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. . BMC Genomics 10:, 642–654. [CrossRef] [PubMed]
    [Google Scholar]
  18. Stephens D. S. , Zughaier S. M. , Whitney C. G. , Baughman W. S. , Barker L. , Gay K. , Jackson D. , Orenstein W. A. , Arnold K. . & other authors ( 2005; ). Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. . Lancet 365:, 855–863. [CrossRef] [PubMed]
    [Google Scholar]
  19. Talbot T. R. , Poehling K. A. , Hartert T. V. , Arbogast P. G. , Halasa N. B. , Mitchel E. , Schaffner W. , Craig A. S. , Edwards K. M. , Griffin M. R. . ( 2004; ). Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. . Clin Infect Dis 39:, 641–648. [CrossRef] [PubMed]
    [Google Scholar]
  20. van Gils E. J. , Veenhoven R. H. , Hak E. , Rodenburg G. D. , Keijzers W. C. , Bogaert D. , Trzcinski K. , Bruin J. P. , van Alphen L. . & other authors ( 2010; ). Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. . JAMA 304:, 1099–1106. [CrossRef] [PubMed]
    [Google Scholar]
  21. Whitney C. G. , Farley M. M. , Hadler J. , Harrison L. H. , Bennett N. M. , Lynfield R. , Reingold A. , Cieslak P. R. , Pilishvili T. . & other authors ( 2003; ). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. . N Engl J Med 348:, 1737–1746. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.058164-0
Loading
/content/journal/jmm/10.1099/jmm.0.058164-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error